ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Other Current Liabilities history
Currency unavailable · from the balance sheet
No Other Current Liabilities data reported for this period type.
Other Current Liabilities vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $119.74M USD | +1274.9% | +57.2% | 48.9% | |
| Mar 2026 | $18.39M USD | +267.0% | +33.9% | 4.1% | |
| Mar 2026 | €10.66M EUR | +1.8% | -13.4% | 10.7% | |
| Mar 2026 | $6.98M USD | — | — | 2.4% | |
| Mar 2026 | $5.52M USD | +23.8% | +13.7% | 0.9% | |
| Mar 2026 | $5.49M USD | -13.6% | +19.8% | 2.2% | |
| Mar 2026 | $4.34M USD | -37.1% | +9.0% | 1.5% | |
| Mar 2026 | $541K USD | +27.0% | +2.1% | 0.3% | |
| Mar 2026 | $0 USD | -100.0% | -14.3% | 0.0% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | +12.8% | +11.4% | 2.2% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.